What one share of Novo Nordisk A/S holds
Novo Nordisk is a global healthcare company and a world leader in Obesity and Diabetes care. The Company manufactures and markets pharmaceutical products and services that make a significant difference to patients, the medical profession and society.
Novo Nordisk A/S’s numbers from its SEC filings, divided by its shares. Results cover the latest fiscal year to 2025-12-31; the balance sheet is as of 2025-12-31.
| Sales | $10.53 |
|---|---|
| Profit | $3.49 |
| Capex (buildings and equipment) | $2.05 |
| Free cash flow | $2.01 |
| Dividends | $1.77 |
| Cash and investments | $0.94 |
| Debt | $4.63 |
| Book value | $6.86 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2019 | $3.85 | $1.23 | $0.28 | $1.19 | — | $1.80 |
| 2020 | $4.15 | $1.38 | $0.19 | $1.51 | $0.70 | $2.21 |
| 2021 | $4.86 | $1.65 | $0.22 | $1.68 | $0.83 | $2.33 |
| 2022 | $5.51 | $1.73 | $0.38 | $2.08 | $0.88 | $2.67 |
| 2023 | $7.50 | $2.70 | $0.83 | $2.68 | $1.36 | $3.55 |
| 2024 | $9.44 | $3.28 | $1.53 | $2.40 | $1.65 | $4.48 |
| 2025 | $10.53 | $3.49 | $2.05 | $2.01 | $1.77 | $6.86 |
Common questions about Novo Nordisk A/S
How much does one share of Novo Nordisk A/S earn?
Over its latest fiscal year, each share of Novo Nordisk A/S earned $3.49 of profit on $10.53 of sales, keeping about 33¢ of every $1 (profit margin).
Does Novo Nordisk A/S pay a dividend?
Yes. Novo Nordisk A/S paid $1.77 per share in dividends over its latest fiscal year, and it paid a dividend in every year from 2020 to 2025 in StockSlicer’s data. That’s about 51¢ of each $1 of profit (payout ratio).
What is Novo Nordisk A/S’s book value per share?
Novo Nordisk A/S’s book value is $6.86 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of December 31, 2025.
How much cash and debt does each share of Novo Nordisk A/S have?
Each share of Novo Nordisk A/S has $0.94 of cash and investments and $4.63 of debt, as of December 31, 2025.
What is Novo Nordisk A/S’s free cash flow per share?
$2.01 per share over its latest fiscal year. Free cash flow is the cash left over after spending on buildings and equipment.
How has Novo Nordisk A/S’s profit per share changed over time?
Profit per share went from $1.23 in 2019 to $3.49 in 2025, growing about 19.0% a year (adjusted for stock splits).
Has Novo Nordisk A/S bought back shares?
Novo Nordisk A/S’s share count fell about 7% from 2019 to 2025. Through buybacks, each remaining share owns a bigger slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.